Awarded

Provision of Tisagenlecleucel CAR-T Cell Therapy to South Metropolitan Health Service

Awarded 30 Oct 2020

View live tenders
Awarded30 Oct 2020
Value$550,000.00
StateWA
CategoryHealth & Medical

South Metropolitan Health Service awarded a contract to Novartis Pharmaceuticals Australia Pty Ltd for the provision of Tisagenlecleucel Chimeric Antigen-Receptor cell therapy.

Similar open tenders12

Suppliers similar to Novartis Pharmaceuticals Australia Pty Ltd8

GovMarket

We do the hard work.
You win the work.

We find the tenders, read the documents and track who wins, so your time goes on bids you can win.

–open health and medical tenders right now
–new in the last 7 days
–contracts awarded in the last 12 months
7 days free, then $59/AUD per month

You're In — Free Trial Activated

You now have full access to GovMarket Premium for 7 days. You’ll be charged at the end of the trial unless you cancel.

  • Tell Us What You Do — We'll surface the tenders that are most relevant to your business.